Gemstone is advising STENOCARE in its ongoing IPO process and this page will give you’re an overview of and access to relevant information and insights. The medical cannabis market is in its infancy, especially in Europe and STENOCARE is the first IPO within medical cannabis in Europe. We know know that the general interest in the market is strong and expect many requests and questions in this regard. For that reason, we have decided to collect relevant information about the market as best we can and as it emerges at the bottom of this page.
Subscription period has ended.
STENOCARE A/S new share issue significantly oversubscribed
Gemstone Capital is advising STENOCARE in its IPO on Spotlight Stock Market. Gemstone Capital has options in STENOCARE, but is not a shareholder. Gemstone is not responsible for any third party content. All content on this page is provided for informational purposes only. It does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell or a recommendation or solicitation of an offer to purchase or sell any relevant financial instruments. For information about STENOCARE and the risks involved in any investment, please read the Memorandum provided carefully.